These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22512741)

  • 1. Psychiatric polypharmacy: a clinical approach based on etiology and differential diagnosis.
    Freudenreich O; Kontos N; Querques J
    Harv Rev Psychiatry; 2012; 20(2):79-85. PubMed ID: 22512741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polypharmacy in psychiatric patients as an alternative to limited mental health resources].
    de las Cuevas C; Sanz EJ; de la Fuente JA; Cueto M
    Actas Esp Psiquiatr; 2005; 33(2):81-6. PubMed ID: 15768314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews.
    Fillit HM; Futterman R; Orland BI; Chim T; Susnow L; Picariello GP; Scheye EC; Spoeri RK; Roglieri JL; Warburton SW
    Am J Manag Care; 1999 May; 5(5):587-94. PubMed ID: 10537865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A view of prescriptive practice collaboration: perspectives of psychiatric-mental health clinical nurse specialists and psychiatrists.
    Kaas MJ; Dehn D; Dahl D; Frank K; Markley J; Hebert P
    Arch Psychiatr Nurs; 2000 Oct; 14(5):222-34. PubMed ID: 11061236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic.
    Glezer A; Byatt N; Cook R; Rothschild AJ
    J Affect Disord; 2009 Sep; 117(1-2):18-23. PubMed ID: 19103462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations.
    Sheppard C; Beyel V; Fracchia J; Merlis S
    Dis Nerv Syst; 1974 Apr; 35(4):183-9. PubMed ID: 17894114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems of polypharmacy.
    Shakib S
    Aust Fam Physician; 2002 Feb; 31(2):125-8. PubMed ID: 11917821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy and the role of physical medicine and rehabilitation.
    Geller AI; Nopkhun W; Dows-Martinez MN; Strasser DC
    PM R; 2012 Mar; 4(3):198-219. PubMed ID: 22443958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
    West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
    J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness.
    Harpaz-Rotem I; Rosenheck RA
    Child Care Health Dev; 2006 Mar; 32(2):225-37. PubMed ID: 16441857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic polypharmacy in outpatients at Birch Hill Hospital: incidence and adherence to guidelines.
    Ranceva N; Ashraf W; Odelola D
    J Clin Pharmacol; 2010 Jun; 50(6):699-704. PubMed ID: 20056801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of a good practice manual on professional practice associated with psychotropic PRN in acute mental health wards: an exploratory study.
    Baker JA; Lovell K; Harris N
    Int J Nurs Stud; 2008 Oct; 45(10):1403-10. PubMed ID: 18313059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethics and evidence in psychiatric practice.
    Gupta M
    Perspect Biol Med; 2009; 52(2):276-88. PubMed ID: 19395825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy in psychiatry: three case studies and methods for prevention.
    Stewart RB; Yedinak KC; Ware MR
    Ann Pharmacother; 1992 Apr; 26(4):529-33. PubMed ID: 1576391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
    Haw C; Stubbs J
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-drug Interactions in Psychiatric Practice, Part 1: Reasons, Importance, and Strategies to Avoid and Recognize Them.
    Preskorn SH
    J Psychiatr Pract; 2018 Jul; 24(4):261-268. PubMed ID: 30427809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-Label Prescribing and Polypharmacy: Minimizing the Risks.
    Leahy LG
    J Psychosoc Nurs Ment Health Serv; 2017 Feb; 55(2):17-22. PubMed ID: 28218925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
    Sokol KC; Knudsen JF; Li MM
    J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.